Join our management team for a presentation at the Jefferies Global Healthcare Conference in London on Monday, November 17th at 2:30 p.m. GMT (9:30 a.m. ET). A live webcast and replay will be available at: www.investors.kiniksa.com
Kiniksa Pharmaceuticals
Biotechnology Research
Lexington, Massachusetts 28,688 followers
Relentless. Passionate. Focused.
About us
Kiniksa is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating diseases by discovering, acquiring, developing, and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. Kiniksa’s portfolio of assets is based on strong biologic rationale or validated mechanisms and offers the potential for differentiation. At Kiniksa, patients are at the heart of everything we do. Our Every Second Counts! mindset reflects our commitment to making a difference for people who are navigating the uncertainty and challenges of life-altering diseases. This is why our team is relentless in pursuing treatments that bring us closer to a better future for patients, every second of every day. We rely on an exceptional team to drive our mission of building a global, generational company. If you're passionate about making a meaningful impact, we’d love to hear from you. Kiniksa offers competitive benefits and dynamic career opportunities across our organization. We foster a culture of passion, innovation, and rapid execution to help fulfill our mission.
- Website
-
http://www.kiniksa.com
External link for Kiniksa Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Lexington, Massachusetts
- Type
- Public Company
- Founded
- 2015
Locations
-
Primary
Get directions
100 Hayden Ave
Lexington, Massachusetts 02421, US
-
Get directions
23 Old Bond Street
Third Floor
London, England W1S 4PZ, GB
-
Get directions
Grafenaustrasse 5
Zug, ZG 6300, CH
-
Get directions
3366 N Torrey Pines Ct
#320
San Diego, California 92037, US
Employees at Kiniksa Pharmaceuticals
-
Alison Reichert
Digital Strategy Leader | Marketing Innovation | Customer Experience | Business Practice Transformation
-
Kelly McCarney
-
Pamela Underwood
Sr. Manager, Global Payroll Operations at Kiniksa Pharmaceuticals Payroll Leader | Trusted Advisor | Employee/Company Advocate
-
Karina Allen-Ludwig, PhD.
Updates
-
The first US guidance for the treatment of recurrent pericarditis has been released. Join us at Booth 3700 at #AHA25 or visit our virtual booth at bit.ly/3JMC6YL to learn more.
-
-
The duration of recurrent pericarditis is much longer than previously thought—often lasting for years. Join us at Booth 3700 at #AHA25 or visit our virtual booth at bit.ly/3JMC6YL to learn more about identifying and treating recurrent pericarditis.
-
-
If you treat pericarditis, it is likely that a patient in your practice has, or will develop, recurrent pericarditis. Join us at Booth 3700 at #AHA25 or visit our virtual booth at bit.ly/3JMC6YL to learn more about the impact of recurrent pericarditis and how it may be treated.
-
-
Attending #AHA25, November 7-10, 2025, in New Orleans? Visit Kiniksa at Booth 3700 to learn about a treatment for recurrent pericarditis. If you can’t attend live, visit our virtual booth at bit.ly/3JMC6YL
-
-
Join us at #AHA25 on Saturday, November 8 at 12:30 pm CT, for a panel discussion and Q&A about evidence-based strategies for the treatment of recurrent pericarditis.
-
-
Attending #AHA25 Scientific Sessions? Stop by to learn more about the American Heart Association Addressing Recurrent Pericarditis initiative: ❤️ American Heart Association Quality Mini Lecture Series Global Quality Pavilion, Science & Technology Hall Booth: #4 in the Heart Hub, Hall E Saturday, 11/8 10:21 – 10:29 AM CT ❤️ American Heart Association Quality Showcase Posters Global Quality Pavilion, Science & Technology Hall Booth: #4 in the Heart Hub, Hall E Saturday, 11/8 3:00 – 4:30 PM CT Register in advance at this link: https://lnkd.in/euRCNz_B #RecurrentPericarditis #HeartHealth #KiniksaCares #Pericarditis Kiniksa Pharmaceuticals is a proud supporter of the American Heart Association’s Addressing Recurrent Pericarditis educational content.
-
-
Sanj and Kristin Patel joined the Kiniksa team to celebrate Diwali – the Festival of Lights. We’re grateful for the opportunity to honor the traditions that bring light, hope, and togetherness to our community. #Diwali #FestivalofLights #TeamKiniksa
-
-
Kiniksa Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution 📄Read the full press release: https://lnkd.in/e2ubnfhJ Join our management team for a live webcast and conference call today: 📅 Time: 8:30 am ET 🎥 Live webcast and replay: investors.kiniksa.com *KPL-387 is an investigational product. The safety and efficacy of KPL-387 have not been evaluated by any regulatory authority.
-
-
📅Save the Date! Join our management team for a conference call and live webcast on Tuesday, October 28th at 8:30 a.m. ET as we report our third quarter financial results and discuss our recent portfolio execution. 🔗 Press release: https://lnkd.in/eQSKskQ2 🎥 Live webcast and replay: https://lnkd.in/eFfKDK-B
-